Born in Naples in 1990, she graduated in Biology and obtained a PhD in Public Health and Preventive Medicine at the University of Naples “Federico II”, where she is currently a Post-doctoral Researcher at the Department of Clinical Medicine and Surgery. She also holds a specialization in Clinical Pathology and Clinical Biochemistry. Her research investigates how endocrine signaling interfaces with oncogenic pathways to shape tumor development and progression, with a particular focus on Thyroid Hormone (TH) signaling in skin cancer. Her work has centred on the TH-activating enzyme type 2 deiodinase (D2) and its integration with key tumor-regulatory pathways, including the p53 network. Through molecular and cellular approaches, she has investigated how alterations in local TH signaling influence tumor-associated processes in keratinocyte carcinomas and cutaneous squamous cell carcinoma. Her research has been supported by two AIRC Foundation fellowships. In 2021, she was awarded the “Michele e Carlo Ardizzone” Fellowship to investigate the functional interplay between p53 and D2 in keratinocyte carcinomas. In 2024, she was awarded the three-year AIRC “GE.S.A.C.” Fellowship for the project “Breaking down the wall between the Thyroid Hormone (TH)-mediated genomic instability and inflammation in skin cancer”. Her current research aims to define how TH-dependent signaling contributes to genomic instability and inflammation in skin cancer, with the broader objective of uncovering mol
Born in Naples in 1990, she graduated in Biology and obtained a PhD in Public Health and Preventive Medicine at the University of Naples “Federico II”, where she is currently a Post-doctoral Researcher at the Department of Clinical Medicine and Surgery. She also holds a specialization in Clinical Pathology and Clinical Biochemistry. Her research investigates how endocrine signaling interfaces with oncogenic pathways to shape tumor development and progression, with a particular focus on Thyroid Hormone (TH) signaling in skin cancer. Her work has centred on the TH-activating enzyme type 2 deiodinase (D2) and its integration with key tumor-regulatory pathways, including the p53 network. Through molecular and cellular approaches, she has investigated how alterations in local TH signaling influence tumor-associated processes in keratinocyte carcinomas and cutaneous squamous cell carcinoma. Her research has been supported by two AIRC Foundation fellowships. In 2021, she was awarded the “Michele e Carlo Ardizzone” Fellowship to investigate the functional interplay between p53 and D2 in keratinocyte carcinomas. In 2024, she was awarded the three-year AIRC “GE.S.A.C.” Fellowship for the project “Breaking down the wall between the Thyroid Hormone (TH)-mediated genomic instability and inflammation in skin cancer”. Her current research aims to define how TH-dependent signaling contributes to genomic instability and inflammation in skin cancer, with the broader objective of uncovering mol